- Report
- April 2024
- 50 Pages
Global
From €2574EUR$2,650USD£2,220GBP
- Report
- March 2024
- 196 Pages
Global
From €3277EUR$3,374USD£2,827GBP
€3641EUR$3,749USD£3,141GBP
- Report
- March 2024
- 196 Pages
Global
From €3277EUR$3,374USD£2,827GBP
€3641EUR$3,749USD£3,141GBP
- Report
- March 2024
- 182 Pages
Global
From €3277EUR$3,374USD£2,827GBP
€3641EUR$3,749USD£3,141GBP
- Report
- March 2024
- 197 Pages
Global
From €3277EUR$3,374USD£2,827GBP
€3641EUR$3,749USD£3,141GBP
- Report
- June 2023
- 100 Pages
Global
From €5779EUR$5,950USD£4,985GBP
- Report
- January 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- January 2024
- 200 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- January 2024
- 142 Pages
Global
From €3787EUR$3,899USD£3,267GBP
- Report
- November 2023
- 175 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Clinical Trials
- April 2024
- 250 Pages
Global
From €2914EUR$3,000USD£2,514GBP
- Clinical Trials
- April 2024
- 150 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Drug Pipelines
- April 2024
- 220 Pages
Global
From €2428EUR$2,500USD£2,095GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Drug Pipelines
- April 2024
- 202 Pages
Global
From €7722EUR$7,950USD£6,661GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1457EUR$1,500USD£1,257GBP
- Clinical Trials
- February 2024
- 180 Pages
Global
From €2914EUR$3,000USD£2,514GBP
- Report
- November 2023
- 224 Pages
Global
From €7284EUR$7,500USD£6,284GBP
- Report
- November 2023
- 181 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Report
- October 2023
- 190 Pages
Global
From €4759EUR$4,900USD£4,106GBP
Methotrexate is a drug used to treat immune disorders, such as rheumatoid arthritis, psoriasis, and Crohn's disease. It works by blocking the action of an enzyme involved in the production of certain proteins that are necessary for the growth and development of cells. It is also used to treat certain types of cancer. Methotrexate is available in both oral and injectable forms.
Methotrexate is a widely used drug in the treatment of immune disorders. It is generally well tolerated and has been shown to be effective in reducing symptoms and improving quality of life. It is also used in combination with other drugs to treat more severe cases of immune disorders.
The market for Methotrexate is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, and AbbVie. Show Less Read more